Thomas William Burns - 02 Jan 2024 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Role
CHAIRMAN & CEO, Director
Signature
Diana Scherer, Attorney-in-Fact
Issuer symbol
GKOS
Transactions as of
02 Jan 2024
Transactions value $
-$6,643,128
Form type
4
Filing time
03 Jan 2024, 18:18:01 UTC
Previous filing
22 Dec 2023
Next filing
10 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GKOS Common Stock Options Exercise $691K +95K +170.14% $7.28 151K 02 Jan 2024 Direct F1
transaction GKOS Common Stock Sale -$3.97M -51.8K -34.32% $76.69 99.1K 02 Jan 2024 Direct F1, F2, F3
transaction GKOS Common Stock Sale -$2.72M -35.1K -35.42% $77.66 64K 02 Jan 2024 Direct F1, F2, F4
transaction GKOS Common Stock Sale -$640K -8.15K -12.74% $78.49 55.8K 02 Jan 2024 Direct F1, F2, F5
holding GKOS Common Stock 894K 02 Jan 2024 Through the Burns Family Trust
holding GKOS Common Stock 238K 02 Jan 2024 Through the Burns Annuity Trust
holding GKOS Common Stock 120K 02 Jan 2024 Through the Burns Charitable Remainder Trust
holding GKOS Common Stock 100K 02 Jan 2024 Through the Thomas W. Burns Irrevocable Trust
holding GKOS Common Stock 100K 02 Jan 2024 Through the Janet M. Burns Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GKOS Stock Option (Right to Buy) Options Exercise $0 -95K -61.24% $0.00 60.1K 02 Jan 2024 Common Stock 95K $7.28 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Includes 47,177 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023.
F3 This transaction was executed in multiple trades at prices ranging from $76.18 to $77.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $77.18 to $78.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $78.21 to $79.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023.
F7 This option was granted on July 10, 2014 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.